NCT06863246Completed
Postural Control in Chronic Obstructive Pulmonary Disease
Influence of Cognitive Load on Postural Control in People With Chronic Obstructive Pulmonary Disease
Source: ClinicalTrials.gov · Last updated 7 Jul 2026
Brief summary (registry, in English)
Postural control impairment is common in people with COPD (pwCOPD), which can increase the risk of falls and affect quality of life. However, the majority of existing studies examine this postural control in isolation, without taking into account the cognitive demands that occur during activities of daily living during which individuals are often required to perform a mental task while maintaining their balance. This research aims to fill this gap by studying how a cognitive task can influence postural control in pwCOPD. We hypothesized an impaired postural control in pwCOPD compared to healthy individuals, which would be exacerbated in presence of a cognitive task.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 36 (actual)
- First submitted
- 3 Mar 2025
- Start date
- 7 Mar 2025
- Primary completion date
- 8 Mar 2025
- Lead sponsor
- Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
- Diseases
- COPD
- NCT number
- NCT06863246
What you commit to
- Study type: Observational
- Participants enrolled: 36
- From 7 Mar 2025 to the primary completion date, 8 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients treated with oral or systemic corticosteroids (\> 0.5 mg / kg / day for \> 7 days)
- Patients treated with oral or systemic corticosteroids (\> 0.5 mg / kg / day for \> 7 days)
Other illness
- Psychiatric pathologies or antecedent of behavioral disorders
- Any condition that, in the opinion of the investigator, could increase and compromise the safety of the person in the event that he / she participates in the study
- Psychiatric pathologies or antecedent of behavioral disorders
- Any condition that, in the opinion of the investigator, could increase and compromise the safety of the person in the event that he / she participates in the study
Other
- COPD patients :
- Alcoholism, i.e. \> 21 glasses a week for men and \>14 glasses a week for women
- Contraindication to the application of a magnetic field (i.e. right hip arthroplasty, pelvic / abdominal surgeries)
- Severe vision or hearing problems not corrected
- Patient oxygen dependent
- Patients in exclusion period from another research protocol
- Pregnant women (known pregnancy) or lactating women
- Patient deprived of liberty by a judicial or administrative decision
- Patient subject to a legal protection measure or unable to express their consent
- Patient who is not sufficiently fluent in reading and understanding the French language to be able to consent to participate in the study
- Patient unable to follow study procedures and to respect visits throughout the study period
- Person with a medical history that, in the opinion of the investigator, could interfere with the results of the study
- Any other reason that, in the opinion of the investigator, could interfere with the evaluation of the aims of the study
- Healthy volunteers:
- Alcoholism, i.e. \> 21 glasses a week for men and \>14 glasses a week for women
- Contraindication to the application of a magnetic field (i.e. right hip arthroplasty, pelvic / abdominal surgeries)
- Severe vision or hearing problems not corrected
- Subjects in exclusion period from another research protocol
- Pregnant women (known pregnancy) or lactating women
- Regular physical activity with a frequency greater than 3 sessions per week
- Participant deprived of liberty by a judicial or administrative decision
- Participant subject to a legal protection measure or unable to express their consent
- Participant who is not sufficiently fluent in reading and understanding the French language to be able to consent to participate in the study
- Participant unable to follow study procedures and to respect visits throughout the study period
- Person with a medical history that, in the opinion of the investigator, could interfere with the results of the study
- Any other reason that, in the opinion of the investigator, could interfere with the evaluation of the aims of the study
Who the study is looking for
- COPD patients :
- GOLD II - III or IV
- FEV1 \<80% of predicted values
- Men and women aged 40 years and over
- French-speaking participant
- BMI \<30 kg / m²
- Stable condition (i.e. without exacerbation) for more than 15 days
- Able to express their consent in writing prior to any participation in the study
- Affiliates or beneficiaries of a social security
- Minimum score of 26 on the MMSE questionnaire of 3 months or less
- Healthy volunteers :
- Men and women aged 40 years and over
- French-speaking participant
- BMI \<30 kg / m²
- No known chronic respiratory, cardiovascular, metabolic, renal or neuromuscular pathologies
- Able to express their consent in writing prior to any participation in the study
- Affiliates or beneficiaries of a social security
- Minimum score of 26 on the MMSE questionnaire of 3 months or less
- For all participants :
- -Subject who has not objected to the reuse of data collected
Age in the registry: 40 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Université de Toulon - Laboratoire J-AP2S Coordinator of this site? Confirm its status | Toulon | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.